Michael Ha

Q: What is Michael Ha's success rate?

Michael Ha currently has a success rate of 98.2904961147639.

Q: What is the average return of Michael Ha's calls?

Their stock ratings have generated an average return of 3.55605303943516.

Baird | Healthcare

Michael Ha is an analyst from Baird specializing in the Healthcare sector. Ranked #2141 out of 4728 analysts, they have issued 20 stock ratings with a success rate of 98.29% and an average return of 3.56%.

Michael Ha has a well-established track record, with 20 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 98.29% and an average return of 3.56%, underscoring their expertise and ability to identify winning opportunities for investors.

#2141

Out of 4728

Total Ratings

+98.29%

Success Rate

+3.56%

Average Return

Recent Ratings Analysis

UNH

Hold

Jul 16, 2026

Target

$453.00

Current

$423.38

Performance

0.00%

Michael Ha rated UNH as Neutral on Jul 16, 2026, setting a price target of 453. The Hold stance appears justified, as shares hovered around 423.38 with a 0.00% move.

ELV

Hold

Jul 16, 2026

Target

$393.00

Current

$372.85

Performance

0.00%

On Jul 16, 2026, ELV was given a Neutral rating by Michael Ha, with a target price of 393. Market indecision, reflected in sideways trading near 372.85, supported the cautious call.

MOH

Hold

May 11, 2026

Target

$163.00

Current

$224.82

Performance

21.40%

MOH received a Neutral rating from Michael Ha on May 11, 2026, aiming for 163. Investors saw gains of 21.40% that the cautious stance didn’t fully capture.

OSCR

Hold

May 07, 2026

Target

$19.00

Current

$28.86

Performance

38.28%

On May 07, 2026, Michael Ha published a Neutral outlook on OSCR, with a target of 19. The Hold call missed some of the bullish momentum as shares advanced toward 19.

THC

Hold

May 05, 2026

Target

$210.00

Current

$199.20

Performance

6.58%

Michael Ha on May 05, 2026 assigned THC a Neutral rating, with a price target of 210. Shares outperformed expectations, climbing 6.58% despite the neutral view.

UHS

Hold

Apr 29, 2026

Target

$204.00

Current

$153.54

Performance

-8.59%

On Apr 29, 2026, Michael Ha reaffirmed UHS with a Neutral rating, targeting 204. The Hold stance reflected market caution that was later justified.

CVS

Buy

Apr 15, 2026

Target

$94.00

Current

$106.50

Performance

—

CVS was rated Outperform by Michael Ha on Apr 15, 2026, with a price objective of 94. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ASTH

Buy

Apr 15, 2026

Target

$40.00

Current

$45.10

Performance

—

On Apr 15, 2026, Michael Ha initiated coverage on ASTH with a Outperform rating and target of 40. Neutral price movement of % leaves room for interpretation.

HCA

Hold

Aug 14, 2025

Target

$423.00

Current

$385.74

Performance

-2.01%

Michael Ha issued a Neutral recommendation for HCA on Aug 14, 2025, price target set at 423. The rating was appropriate for a consolidating market trading near 385.74.

CI

Buy

Aug 14, 2025

Target

$374.00

Current

$283.82

Performance

-2.25%

On Aug 14, 2025, CI was evaluated by Michael Ha, who gave a Outperform rating and target of 374. So far, the Buy call awaits clearer momentum, with shares flat at 283.82.

HUM

Hold

Jul 25, 2025

Target

$297.00

Current

$386.68

Performance

62.48%

Michael Ha rated HUM as Neutral on Jul 25, 2025, setting a price target of 297. Despite the Hold call, shares climbed 62.48% to 386.68, revealing unexpected momentum.

CNC

Hold

Jul 25, 2025

Target

$28.00

Current

$63.90

Performance

125.09%

On Jul 25, 2025, CNC was given a Neutral rating by Michael Ha, with a target price of 28. The stock rallied from 63.903 to 63.903 after the Hold rating, surprising to the upside.

PRVA

Buy

Aug 26, 2024

Target

$24.00

Current

$27.22

Performance

27.85%

PRVA received a Outperform rating from Michael Ha on Aug 26, 2024, aiming for 24. Momentum has favored the Buy call, with shares climbing from 27.22 to 27.22, rewarding those who trusted the recommendation.

ALHC

Buy

Aug 14, 2024

Target

$11.00

Current

$20.03

Performance

131.03%

On Aug 14, 2024, Michael Ha published a Outperform outlook on ALHC, with a target of 11. Shares gained 131.03%, underscoring the accuracy of the bullish outlook toward 11.

Frequency Asked Questions

Who is Michael Ha?

Michael Ha is an analyst from Baird specializing in the Healthcare sector.

What is Michael Ha's success rate?

Michael Ha currently has a success rate of +98.29%.

How many ratings has Michael Ha issued?

Michael Ha has issued 20 stock ratings so far.

What is the average return of Michael Ha's calls?

Their stock ratings have generated an average return of +3.56%.

What is Michael Ha's ranking?

Michael Ha is ranked #2141 out of 4728 analysts.

What types of ratings does Michael Ha give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Michael Ha?

You can follow Michael Ha by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Michael Ha?

Their latest rating was a Hold on UNH issued on 2026-07-16.